Lazard Asset Management LLC holds a diversified book of 1844 stocks worth $60.7B as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened AstraZeneca PLC and trimmed Alphabet Inc-CL A. Their largest long position is Apple Inc at 3% of the equity book. They also disclosed $9.5M in put options (a bearish bet) and $38.2M in call options (bullish), shown separately below and excluded from the equity book.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
98% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Lazard Asset Management LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| BlackRock, Inc. | 80 / 80 | $2.3T |
| JPMORGAN CHASE & CO | 80 / 80 | $532.0B |
| MORGAN STANLEY | 80 / 80 | $515.1B |
| BANK OF AMERICA CORP /DE/ | 80 / 80 | $308.3B |
| NORTHERN TRUST CORP | 80 / 80 | $302.6B |
| GOLDMAN SACHS GROUP INC | 80 / 80 | $242.4B |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | 80 / 80 | $220.0B |
| ROYAL BANK OF CANADA | 80 / 80 | $165.7B |
Ranked by how many of Lazard Asset Management LLC's top 80 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Apple Inc COM | $2.1B | 8.24M | 3.4% | ▲+12% Added · +866K sh | |
| 2 | Microsoft Corp COM | $2.0B | 5.30M | 3.2% | ▲+7.6% Added · +373K sh | |
| 3 | Nvidia Corporation COM | $1.8B | 10.32M | 3.0% | ▲+23% Added · +1.9M sh | |
| 4 | Amazon Com Inc COM | $1.6B | 7.71M | 2.6% | ▲+6.5% Added · +473K sh | |
| 5 | American Tower Corp COM | $1.3B | 7.33M | 2.1% | ▲+20% Added · +1.2M sh | |
| 6 | Exelon Corp COM | $1.2B | 24.62M | 2.0% | ▲+6.4% Added · +1.5M sh | |
| 7 | Crown Castle Inc COM | $1.1B | 13.46M | 1.8% | ▲+16% Added · +1.8M sh | |
| 8 | Alphabet Inc CAP STK CL A | $1.0B | 3.51M | 1.7% | ▼−0.3% Reduced · −11K sh | |
| 9 | Taiwan Semiconductor Manufac SPONSORED ADS | $996.7M | 2.95M | 1.6% | ▼−9.3% Reduced · −301K sh | |
| 10 | Alphabet Inc CAP STK CL C | $987.1M | 3.44M | 1.6% | ▲+20% Added · +565K sh | |
| 11 | Canadian Natl Ry Co COM | $934.5M | 9.08M | 1.5% | ▲+1.9% Added · +174K sh | |
| 12 | Broadcom Inc COM | $842.4M | 2.72M | 1.4% | ▲+12% Added · +300K sh | |
| 13 | Ferrovial SE ORD SHS | $830.4M | 12.97M | 1.4% | ▼−3.8% Reduced · −516K sh | |
| 14 | Consolidated Edison Inc COM | $800.8M | 7.08M | 1.3% | ▲+15% Added · +910K sh | |
| 15 | CSX Corp COM | $752.6M | 18.33M | 1.2% | ▼−11% Reduced · −2.3M sh | |
| 16 | Visa Inc COM CL A | $729.8M | 2.41M | 1.2% | ▲+2.3% Added · +55K sh | |
| 17 | Eli Lilly & Co COM | $660.5M | 718.1K | 1.1% | ▲+7.2% Added · +48K sh | |
| 18 | Thermo Fisher Scientific Inc COM | $600.7M | 1.22M | 1.0% | ▼−1.0% Reduced · −12K sh | |
| 19 | Analog Devices Inc COM | $543.7M | 1.71M | 0.9% | ▲+6.3% Added · +101K sh | |
| 20 | Bank America Corp COM | $540.7M | 11.09M | 0.9% | ▲+5.6% Added · +591K sh | |
| 21 | America Movil SAB De CV SPON ADS RP CL B | $530.2M | 20.81M | 0.9% | ▲+18% Added · +3.1M sh | |
| 22 | Petroleo Brasileiro S A SPONSORED ADR | $524.0M | 25.25M | 0.9% | ▲+9.0% Added · +2.1M sh | |
| 23 | Procter & Gamble Co COM | $516.6M | 3.58M | 0.9% | ▼−0.5% Reduced · −18K sh | |
| 24 | Intercontinental Exchange In COM | $514.5M | 3.27M | 0.8% | ▲~0% Added · +1K sh | |
| 25 | Telekomunikasi Ind SPONSORED ADR | $469.4M | 25.13M | 0.8% | ▲+23% Added · +4.8M sh | |
| 26 | ASML Hldg NV N Y REGISTRY SHS | $448.6M | 339.6K | 0.7% | ▲+26% Added · +70K sh | |
| 27 | AstraZeneca PLC ORD | $432.8M | 2.22M | 0.7% | ▲New New position | |
| 28 | Kla Corp COM NEW | $430.7M | 292.5K | 0.7% | ▲+14% Added · +35K sh | |
| 29 | SLB Limited COM STK | $403.9M | 7.86M | 0.7% | ▼−13% Reduced · −1.1M sh | |
| 30 | Amphenol Corp CL A | $401.7M | 3.18M | 0.7% | ▼−15% Reduced · −574K sh | |
| 31 | Aon PLC SHS CL A | $392.9M | 1.22M | 0.6% | ▼−5.3% Reduced · −69K sh | |
| 32 | Merck & Co Inc COM | $391.5M | 3.25M | 0.6% | ▼−26% Reduced · −1.2M sh | |
| 33 | Danaher Corp Del COM | $384.7M | 2.03M | 0.6% | ▼−6.6% Reduced · −144K sh | |
| 34 | Vale S A SPONSORED ADS | $376.8M | 23.69M | 0.6% | ▲+5.4% Added · +1.2M sh | |
| 35 | Meta Platforms Inc CL A | $364.4M | 637.0K | 0.6% | ▲+17% Added · +94K sh | |
| 36 | Infosys Ltd SPONSORED ADR | $361.8M | 26.78M | 0.6% | ▲+17% Added · +3.9M sh | |
| 37 | Exxon Mobil Corp COM | $355.5M | 2.10M | 0.6% | ▼−1.8% Reduced · −39K sh | |
| 38 | Ametek Inc COM | $346.9M | 1.62M | 0.6% | ▲+4.6% Added · +71K sh | |
| 39 | Palo Alto Networks Inc COM | $332.4M | 2.07M | 0.5% | ▲+83% Added · +939K sh | |
| 40 | Qualcomm Inc COM | $327.4M | 2.54M | 0.5% | ▲+11% Added · +256K sh | |
| 41 | Linde PLC SHS | $324.8M | 654.9K | 0.5% | ▲+1.5% Added · +10K sh | |
| 42 | Waste Mgmt Inc Del COM | $318.6M | 1.39M | 0.5% | ▲+0.6% Added · +8K sh | |
| 43 | Johnson & Johnson COM | $318.5M | 1.30M | 0.5% | ▲+44% Added · +398K sh | |
| 44 | Iqvia Hldgs Inc COM | $317.0M | 1.86M | 0.5% | ▼−2.0% Reduced · −38K sh | |
| 45 | Chubb Ltd Switz COM | $316.7M | 971.7K | 0.5% | ▼−7.9% Reduced · −83K sh | |
| 46 | Coca Cola Co COM | $312.8M | 4.11M | 0.5% | ▲+0.7% Added · +31K sh | |
| 47 | Boston Scientific Corp COM | $306.3M | 4.88M | 0.5% | ▲+25% Added · +970K sh | |
| 48 | Intuitive Surgical Inc COM NEW | $299.0M | 648.6K | 0.5% | ▲+18% Added · +100K sh | |
| 49 | Autodesk Inc COM | $299.0M | 1.25M | 0.5% | ▲+11% Added · +128K sh | |
| 50 | Ase Technology Hldg Co Ltd SPONSORED ADS | $293.3M | 13.53M | 0.5% | ▼−32% Reduced · −6.5M sh |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1207017/holdings"
Use Arkolith to show LAZARD ASSET MANAGEMENT LLC's latest holdings, largest changes, and filing provenance.
Put / call positions from the 13F — totals include every disclosed option leg
| Type | Underlying | Notional value | Underlying shares |
|---|---|---|---|
| CALL · bullish | SS SPDR S&P 500 ETF TRUST-USSPY | $23.4M | 36K |
| CALL · bullish | BRIDGEBIO PHARMA INCBBIO | $5.9M | 80K |
| PUT · bearish | BRIDGEBIO PHARMA INCBBIO | $4.2M | 56K |
| CALL · bullish | GUARDANT HEALTH INCGH | $4.2M | 45K |
| PUT · bearish | GUARDANT HEALTH INCGH | $3.3M | 36K |
| CALL · bullish | SHIFT4 PAYMENTS INC-CLASS AFOUR | $1.5M | 35K |
| PUT · bearish | PAGAYA TECHNOLOGIES LTD -APGY | $1.2M | 100K |
| CALL · bullish | DROPBOX INC-CLASS ADBX | $1.1M | 50K |
| CALL · bullish | INDIE SEMICONDUCTOR INC-AINDI | $966K | 300K |
| CALL · bullish | GALAXY DIGITAL INC-AGLXY | $923K | 50K |
| PUT · bearish | INDIE SEMICONDUCTOR INC-AINDI | $805K | 250K |
| CALL · bullish | B2GOLD CORPBTG | $113K | 25K |
13F filers disclose option positions at the market value of the underlying the contracts reference, not the premium paid. A put is a bearish bet (it gains if the stock falls); a call is bullish. “Underlying shares” is the share count the contracts control, not a share holding. These legs are excluded from the equity book, weighting, concentration and sector figures above.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 2,050 | $60.8B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 17, 2026 | 2,068 | $59.0B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 2,000 | $74.3B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 3,684 | $72.7B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 | 3,727 | $65.1B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 3,807 | $68.4B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 | 3,726 | $74.8B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 | 3,826 | $79.7B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | Jul 9, 2024 | 3,146 | $82.3B | 13F-HR/A |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 3,401 | $79.0B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 | 3,410 | $73.5B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 15, 2023 | 3,403 | $81.2B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 3,201 | $76.3B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 15, 2023 | 3,227 | $72.6B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 3,169 | $68.4B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 9, 2022 | 3,268 | $73.9B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 13, 2022 | 3,199 | $86.3B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 9, 2022 | 3,062 | $94.0B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 15, 2021 | 3,015 | $88.6B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 12, 2021 | 2,652 | $89.1B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 14, 2021 | 2,476 | $82.6B | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 11, 2021 | 2,436 | $79.1B | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 13, 2020 | 2,175 | $71.1B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.